Founded in 2025 by Joel Grajcer and Dr. Kevin Najafi, Loovi provides what it bills as Europe’s first end-to-end digital platform for longevity and preventive healthcare. The service aggregates blood markers, physical test data, and wearable-device information into a single interface, then applies an AI-driven analytical layer to deliver personalised, medically contextualised recommendations. Unlike traditional, one-off health check-ups, Loovi runs as an ongoing programme that emphasises continuous monitoring, realistic lifestyle adjustments, and long-term habit formation. Users receive both technological insights and human guidance to interpret their data and maintain sustainable health routines. The platform was developed and pilot-tested over the past year, and the company reports that much of current healthcare remains reactive—an issue it aims to address by surfacing early warning signs and facilitating structured prevention. Proceeds from its latest financing will fund further product development, bolster medical and technical resources, and support a broader market rollout. Financially, Loovi has announced a €1 million raise to launch and scale the platform; no revenue or user figures have been disclosed.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2026